EndoChoice (GI) Tops Q3 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
EndoChoice Announces Third Quarter 2015 Financial Results
November 5, 2015 7:00 AM ESTALPHARETTA, Ga., Nov. 5, 2015 /PRNewswire/ -- EndoChoice Holdings, Inc. (NYSE:Â GI) announced today financial results for the third quarter 2015.
Highlights
Total revenue of $18.4 million, up 30% year-over-year (32% in constant currency) Installed base of Fuse®  now exceeds 100 systems Pathology revenue accelerating; 23% growth in specimens processed and 8% growth in number of customers year-over-year International revenue up 188% year-over-year, now 12% of total revenue compared to 5% in Q3 2014 Updated full year 2015 financial guidanceMark Gilreath, Founder and Chief Executive Officer of EndoChoice, said, "We delivered strong results in the... More
